From: A review of national action plans on antimicrobial resistance: strengths and weaknesses
Region | Country | ||||
---|---|---|---|---|---|
 | National action plan in English | Number | National action plan not English | Number | Total number |
Africa | Eritrea Eswatini Ethiopia Ghana Kenya Liberia Malawi Mauritius Nigeria Sierra Leone South Africa United Republic of Tanzania Zambia Zimbabwe | 14 | Burkina Faso | 1 | 15 |
Americas | Barbados Canada United States of America | 3 | Argentina Brazil Costa Rica Paraguay Peru | 5 | 8 |
Eastern Mediterranean | Afghanistan Bahrain Egypt Iran Iraq Jordan Kingdom of Saudi Arabia Lebanon Libya Oman Pakistan Palestine Sudan United Arab Emirates | 14 | Morocco Tunisia | 2 | 16 |
Europe | Belgium Czech Republic Denmark Finland France Germany Ireland Italy Netherlands Norway Republic of Serbia Spain Sweden Tajikistan The Former Yugoslav Republic of Macedonia Turkmenistan United Kingdom of Great Britain and Northern Ireland | 17 | Armenia Austria Cyprus Greece Lithuania Republic of Montenegro Portugal | 7 | 24 |
South-East Asia | Bangladesh Bhutan Democratic Republic of Timor Leste DPR of Korea India Indonesia Maldives Sri Lanka Thailand | 9 | Â | 0 | 9 |
Western Pacific | Australia Cambodia China Federated States of Micronesia Fiji Japan Lao PDR Mongolia Nauru Papua New Guinea Philippines Republic of Marshall Islands Tuvalu | 13 | Republic of Korea | 1 | 14 |
 | Total | 70 |  | 16 | 86 |